Abstract
e13587 Background: Infusional 5FU schedules remain the backbone of conventional regimens for gastric cancer (GC) patients (pts). 5-FU pharmacokinetic variability when posology is calculated by the ...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
